|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
12 February 2013 |
|
Main ID: |
ISRCTN54378178 |
|
Date of registration:
|
20/12/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Asthma: a disease due to a lack of bacterial infections in childhood
INDIAAN |
|
Scientific title:
|
|
|
Date of first enrolment:
|
Jan 1 1999 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Completed/Not recruiting |
|
URL:
|
http://isrctn.org/ISRCTN54378178 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised, single blind, placebo controlled, parallel group trial
|
|
|
Countries of recruitment
|
|
Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
M O
Hoekstra |
|
Address:
|
University Medical Centre Utrecht
Wilhelmina Children's Hospital
P.O. Box 85090
3508 AB
Utrecht
Netherlands |
|
Telephone:
|
+31 (0)30 250 4001 |
|
Email:
|
m.o.hoekstra@umcutrecht.nl |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: High-risk newborns. High-risk was defined as either a mother or a father plus a sibling with present or past atopic disease.
Exclusion criteria: 1. Maternal infection in the last week of pregnancy
2. The use of immunomodulatory drugs or antibiotics during pregnancy (mother)
3. The use of antibiotics prenatally (mother and newborn)
4. Prematurity
5. Signs of intra-uterine infection
6. Premature rupture of membranes
7. Presence of congenital disorders of the airways
8. Sever other congenital disorders
9. Need for mechanical ventilation
10. Prolonged administration of extra oxygen
11. Need for intensive care treatment
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
Atopic disease, asthma
|
|
Intervention(s)
|
|
BCG vaccination or placebo.
|
|
Primary Outcome(s)
|
|
Incidence and severity of atopic disease at the age of 4 years.
|
|
Secondary Outcome(s)
|
1. SCORing Atopic Dermatitis (SCORAD)
2. Lung function
3. Cytokine production
4. Natural Resistance Associated Macrophage Protein (NRAMP) polymorphisms
|
|
Secondary ID(s)
|
|
|
|
NWO-NAF 3.2.93.96.2
|
|
Source(s) of Monetary Support
|
|
1. The Netherlands Organization for Scientific Research (NWO) (The Netherlands)
2. Netherlands Asthma Foundation (The Netherlands)
|
|